Cargando…

Epithelial–Mesenchymal Transition Contributes to Docetaxel Resistance in Human Non-Small Cell Lung Cancer

Lung cancer is an aggressive malignancy with high morbidity and mortality. Chemotherapy has always been the principal treatment measure, but its acquired resistance becomes a critical problem. In the current study, we established a new docetaxel-resistant human non-small lung cancer (NSCLC) cell lin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Weiwei, Pang, Hailin, Liu, Jiayu, Zhou, Jing, Zhang, Feng, Liu, Lele, Ma, Ningqiang, Zhang, Ning, Zhang, Helong, Liu, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592784/ https://www.ncbi.nlm.nih.gov/pubmed/25700358 http://dx.doi.org/10.3727/096504014X14098532393473

Ejemplares similares

The Biological Effects of Dickkopf1 on Small Cell Lung Cancer Cells and Bone Metastasis
por: Pang, Hailin, et al.
Publicado: (2017)

Risk factors for bone metastasis in patients with primary lung cancer: A systematic review
por: Niu, Yujie, et al.
Publicado: (2019)

The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions
por: Liu, Qiqi, et al.
Publicado: (2016)

Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway
por: Pan, Yan, et al.
Publicado: (2017)

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies
por: Qiao, Lili, et al.
Publicado: (2022)

Long Noncoding RNA LINC00909 Induces Epithelial-Mesenchymal Transition and Contributes to Osteosarcoma Tumorigenesis and Metastasis
por: Liu, Wanshun, et al.
Publicado: (2022)

Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer
por: XU, KE, et al.
Publicado: (2015)

Epithelial-Mesenchymal Transition in tumor microenvironment
por: Jing, Yingying, et al.
Publicado: (2011)

Lobetyolin suppressed lung cancer in a mouse model by inhibiting epithelial-mesenchymal transition
por: Liu, Lu, et al.
Publicado: (2022)

Epithelial–mesenchymal transition in organ fibrosis development: current understanding and treatment strategies
por: Liu, Lexin, et al.
Publicado: (2022)

Downregulation of NDR1 contributes to metastasis of prostate cancer cells via activating epithelial‐mesenchymal transition
por: Yue, Juntao, et al.
Publicado: (2018)

LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition
por: Li, Jing, et al.
Publicado: (2019)

An electrochemical biosensor for the detection of epithelial-mesenchymal transition
por: Du, Xin, et al.
Publicado: (2020)

DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer
por: Chen, Xianliang, et al.
Publicado: (2015)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression
por: Krantz, Seth B., et al.
Publicado: (2010)

SET contributes to the epithelial-mesenchymal transition of pancreatic cancer
por: Mody, Hardik R., et al.
Publicado: (2017)

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)

Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis
por: Du, Liang, et al.
Publicado: (2017)

Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Jiang, Yi, et al.
Publicado: (2019)

The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition
por: Liu, Peng, et al.
Publicado: (2022)

The role of epithelial–mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel‐resistant prostate cancer
por: Hanrahan, Karen, et al.
Publicado: (2017)

Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers
por: Mitra Ghosh, Taraswi, et al.
Publicado: (2023)

Curcumin Inhibits Proliferation and Epithelial-Mesenchymal Transition in Lens Epithelial Cells through Multiple Pathways
por: Liu, Huijun, et al.
Publicado: (2020)

CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer
por: Chen, Binshen, et al.
Publicado: (2020)

∆9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer
por: Zhang, Yingzhi, et al.
Publicado: (2018)

The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition
por: Zhou, Linlin, et al.
Publicado: (2023)

Synaptotagmin 7 in twist-related protein 1-mediated epithelial – Mesenchymal transition of non-small cell lung cancer
por: Liu, Xiao, et al.
Publicado: (2019)

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis
por: Wang, Changli, et al.
Publicado: (2012)

Apatinib inhibits macrophage-mediated epithelial–mesenchymal transition in lung cancer
por: Liu, Shuliang, et al.
Publicado: (2018)

miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition
por: Wang, Lin, et al.
Publicado: (2015)

Vitamin D Enhances Radiosensitivity of Colorectal Cancer by Reversing Epithelial-Mesenchymal Transition
por: Yu, Xinyue, et al.
Publicado: (2021)

HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
por: Xu, Long, et al.
Publicado: (2022)

Genome-wide identification of epithelial-mesenchymal transition-associated microRNAs reveals novel targets for glioblastoma therapy
por: Zhang, Yong, et al.
Publicado: (2018)

Alpha-1 Antitrypsin Induces Epithelial-to-Mesenchymal Transition, Endothelial-to-Mesenchymal Transition, and Drug Resistance in Lung Cancer Cells
por: Wu, Dong-ming, et al.
Publicado: (2020)

TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis
por: Wu, Jingni, et al.
Publicado: (2020)

Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells
por: Lee, An-Fu, et al.
Publicado: (2017)

DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells
por: Zhang, Lili, et al.
Publicado: (2018)

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
por: Bonde, Anne-Katrine, et al.
Publicado: (2012)

Bufalin inhibits epithelial-mesenchymal transition and increases radiosensitivity of non-small cell lung cancer via inhibition of the Src signaling
por: Wang, Zijian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8bjdb9h17hq91u3vigct65f45s